David Atkinson
Managing Partner @ Tate & Lyle Ventures
London, United Kingdom
David Atkinson is a pre-seed investor at Tate & Lyle Ventures in London focused on Biotechnology and Nutrition. David Atkinson having held a number of senior management positions in the City brings a background in investment banking with a close association with the food industry to the team. He currently serves as a director of BioFilm Holdings Ltd. (UK), Fugeia NV (Belgium) and Lumora Ltd. (UK).David spent over 14 years in equity research specificallyfocused on the food processing industry. David worked at SG Warburg Securities before joining NatWest Securities to head up the pan-European Food Producers research team. During his time in charge the team was consistently top-three ranked in the Extel and Institutional Investor buy-side surveys. David was appointed Managing Director and Head of European Research at NatWest Securities in 1996 and was a member of the Equities Management Committee. In 1998, David co-founded Stamford Partners, one of the leading investment banking firms providing merger and acquisition and strategic consulting services to the European food industry, where he further developed his extensive food industry network. David has also held several senior management positions in the equities operations of Banc of America Securities as well as providing consultancy services to HSBC and the VC industry.
- Total investments:
- 5
- Last investment:
- Lead investor:
- 40%
Last updated:
For AI agents: llms.txt
Industries David Atkinson invests in
Stages David Atkinson invests in
Countries David Atkinson invests in
Contacts
| Type | Contact | Validation |
|---|---|---|
| Work email | ||
| Personal email | ||
| Work phone | ||
| Personal phone | ||
| Socials |
Investment Focus
Industry
- Biotechnology 2 (40%)
- Nutrition 1 (20%)
- Blockchain 1 (20%)
- Social Impact 1 (20%)
- Web Development 1 (20%)
Stage
- Pre-Seed 1 (20%)
- Series A 1 (20%)
- Series B 1 (20%)
- Funding Round 1 (20%)
Country
- United States 1 (20%)
- United Kingdom 1 (20%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Dapps
|
Dapps make it simple for web3 applications to integrate and communicate with one another on the blockchain, enabling you to easily attain the highest level of discoverability within and outside of the community. | Pre-Seed / Dec 23, 2022 | |
Nutriati
|
Nutriati is a food technology company focused on the research, development and commercialization of innovative plant-based food ingredients. It is dedicated to formulating nutritious food products that are widely attractive to a broad range of consumer tastes. The company's business strategy includes a commitment to positive social impactand the promotion and distribution of healthier component ingredients in the food supply, resulting in improved health and well-being globally.Nutriati was founded in 2013 and is headquartered in Richmond, Virginia, United States. | $8M / Series A / Apr 21, 2017 | |
Lumora
|
Lumora Ltd, a Cambridgeshire Business Park, UK-based molecular diagnostics company. The company intends to use the funds to accelerate its entry into the clinical molecular diagnostic market. Based on its proprietary BART Technology platform, Lumora is developing programs focusing on:- an integrated testing station for gastrointestinal (GI)infections, and- an HIV viral load monitoring system to support drug therapy in the developing world. | $917K / Mar 19, 2013 | |
|
Lumora
|
Lumora Ltd, a Cambridgeshire Business Park, UK-based molecular diagnostics company. The company intends to use the funds to accelerate its entry into the clinical molecular diagnostic market. Based on its proprietary BART Technology platform, Lumora is developing programs focusing on:- an integrated testing station for gastrointestinal (GI)infections, and- an HIV viral load monitoring system to support drug therapy in the developing world. | $2M / Series B / May 26, 2011 | |
|
Lumora
|
Lumora Ltd, a Cambridgeshire Business Park, UK-based molecular diagnostics company. The company intends to use the funds to accelerate its entry into the clinical molecular diagnostic market. Based on its proprietary BART Technology platform, Lumora is developing programs focusing on:- an integrated testing station for gastrointestinal (GI)infections, and- an HIV viral load monitoring system to support drug therapy in the developing world. |
Co-Investors
About Tate & Lyle Ventures
Tate & Lyle Ventures is a £25M venture capital fund focused on investing in high growth companies in the fields of renewable ingredients, food technologies, biomaterials and industrial processing technologies. Their cornerstone investor is Tate & Lyle PLC, one of the world's leading renewable ingredients companies focused oninnovation and product development in these sectors.They are proactive investors investing practically as well as financially by supporting the management teams they back with experience, strategy and networks. They prefer to work as lead investors but occasionally work as syndicate members alongside other investors such as business angels, venture capital funds and corporate investors.They can invest in businesses around the world. They invest in technology-based businesses across food science and technology. They generally make an initial investment of £1-2M followed by further amounts of follow-on investment. They consider smaller investments and seed deals when the business is on a very steep growth curve leading to greater capital requirements.
Tate & Lyle Ventures Contacts
| Name | Phone | Socials | |
|---|---|---|---|
|
David Atkinson
Managing Partner
|
|||
Simon Barnes
Managing Partner
|
|||
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Recommended lists
FAQ
What does David Atkinson invest in?
David Atkinson invests primarily in Biotechnology, Nutrition and Blockchain startups, most often at Pre-Seed and Series A stage. Most of the 5 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact David Atkinson?
Public channels for David Atkinson include LinkedIn. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
When did David Atkinson last invest?
The most recent investment recorded for David Atkinson closed in Dec 2022. Shizune tracks 5 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
